Biomedical Engineering Reference
In-Depth Information
Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., Thomson, J.A., 2005. Basic FGF and
suppression of BMP signaling sustain undifferentiated proliferation of human ES cells.
Nat Methods 2, 185-190.
Xu, R.H., Sampsell-Barron, T.L., Gu, F., Root, S., Peck, R.M., Pan, G., Yu, J., Antosiewicz-
Bourget, J., Tian, S., Stewart, R., Thomson, J.A., 2008. NANOG is a direct target of
TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3, 196-206.
Yamanaka, S., 2008. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B
Biol Sci 363(1500), 2079-2087.
Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J.,
Zhang, Y., 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcrip-
tion activation by androgen receptor. Cell 125, 483-495.
Yang, W.J., Yang, D.D., Na, S., Sandusky, G.E., Zhang, Q., Zhao, G., 2005. Dicer is required
for embryonic angiogenesis during mouse development. J Biol Chem 280, 9330-9335.
Yeom, Y.I., Ha, H.S., Balling, R., Scholer, H.R., Artzt, K., 1991. Structure, expression and
chromosomal location of the Oct-4 gene. Mech Dev 35, 171-179.
Ying, Q.L., Nichols, J., Chambers, I., Smith, A., 2003. BMP induction of Id proteins
suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration
with STAT3. Cell 115, 281-292.
Yoshida, K., Chambers, I., Nichols, J., Smith, A., Saito, M., Yasukawa, K., Shoyab, M.,
Taga, T., Kishimoto, T., 1994. Maintenance of the pluripotential phenotype of embryonic
stem cells through direct activation of gp130 signalling pathways. Mech Dev 45, 163-171.
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H.,
Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K.,
Wang, W.Z., Mori, C., Shiota, K., Yoshida, N., Kishimoto, T., 1996. Targeted disruption
of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to
myocardial and hematological disorders. Proc Natl Acad Sci U S A 93, 407-411.
Yuan, H., Corbi, N., Basilico, C., Dailey, L., 1995. Developmental-specific activity of the
FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9,
2635-2645.
Zappone, M.V., Galli, R., Catena, R., Meani, N., De Biasi, S., Mattei, E., Tiveron, C.,
Vescovi, A.L., Lovell-Badge, R., Ottolenghi, S., Nicolis, S.K., 2000. Sox2 regulatory
sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells
and precursors of the mouse embryo, revealing regionalization of gene expression in CNS
stem cells. Development 127, 2367-2382.
Zhang, B., Pan, X., Anderson, T.A., 2006a. MicroRNA: a new player in stem cells. J Cell
Physiol 209, 266-269.
Zhang, J., Tam, W.L., Tong, G.Q., Wu, Q., Chan, H.Y., Soh, B.S., Lou, Y., Yang, J., Ma, Y.,
Chai, L., Ng, H.H., Lufkin, T., Robson, P., Lim, B., 2006b. Sall4 modulates embryonic
stem cell pluripotency and early embryonic development by the transcriptional regulation
of Pou5f1. Nat Cell Biol 8, 1114-1123.
